Sort
51,593 grants matching “hepatitis”
Control of stellate cells-driven liver cancer by the p62/NBR1 adapters
$433,352Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · DK
Control of stellate cells-driven liver cancer by the p62/NBR1 adapters
$433,352Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · DK
Control of stellate cells-driven liver cancer by the p62/NBR1 adapters
$433,352Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · DK
Role of Inflammation in tumor promotion and progression
$433,300Michael Karin · University Of California, San Diego · R01 · FY2014 · CA
Multivalent Vaccine for Opiate Addiction
$433,232Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2012 · DA
Technologies and Resources for Core Laboratories
$433,182Laura F Gibson · West Virginia University · U54 · FY2021 · GM
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
$433,180P. Duc Si Dong · Scintillon Institute For Photobiology · R01 · FY2025 · DK
Development of mosaic enterovirus mRNA vaccine to prevent hand, foot and mouth disease
$433,175Todd Christopher Bradley · Children'S Mercy Hosp (Kansas City, Mo) · R21 · FY2025 · AI
Tuberous Sclerosis-Pathway and Pathogenesis
$433,144David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2009 · CA
TIM-4 Signaling in NASH Liver Transplant Ischemia/Reperfusion Injury
$433,125Haofeng Ji · University Of California Los Angeles · R21 · FY2025 · AI
Small Molecule Inhibitors Against HPV-Induced Orophageal Cancers
$433,125Otto O Yang · University Of California Los Angeles · R21 · FY2025 · DE
HDL, Inflammation and Atherosclerosis
$433,121Alan Chait · University Of Washington · P01 · FY2010 · HL
Group testing for infectious disease detection
$433,066Christopher R Bilder · University Of Nebraska Lincoln · R01 · FY2022 · AI
Metabolic basis of the NADPH-independent disulfide reductase system in mouse liver
$433,045Edward E Schmidt · Montana State University - Bozeman · R01 · FY2021 · DK
TLR-4 In Liver Immunoregulation
$433,042Ian Nicholas Crispe · Seattle Biomedical Research Institute · R01 · FY2009 · AI
TLR-4 In Liver Immunoregulation
$433,042Ian Nicholas Crispe · Seattle Biomedical Research Institute · R01 · FY2010 · AI
Case-only Cancer Clustering for Mobile Populations
$433,039Geoffrey M. Jacquez · Biomedware · R44 · FY2009 · CA
Structure and Assembly of Membrane Proteins at Tight Junctions
$433,038Alex J. Vecchio · State University Of New York At Buffalo · R35 · FY2025 · GM
A novel CREBH-derived hepatokine regulates triglyceride metabolism
$432,970Kezhong Zhang · Wayne State University · R01 · FY2023 · DK
Training
$432,911Patricia A Totten · Path · U54 · FY2011 · EB
Development of cell-free DNA assays for HCC screening and liquid biopsy
$432,900Ying-Hsiu Su · Baruch S. Blumberg Institute · R01 · FY2016 · CA
New broad-spectrum antivirals: target bunyaviruses
$432,891Hepadnavirus Testing, Inc. · R43 · FY2004 · AI
Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + Smokers
$432,874Robert Gross · University Of Pennsylvania · R01 · FY2022 · HL
Carbohydrate Metabolic Pathways
$432,861Case Western Reserve University · R01 · FY2005 · DK
Immune suppressor mechanism in a murine model of hepatitis and liver cancer
$432,799Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA